Smith & Nephew Director Invests in Company Shares
Smith & Nephew Announces CEO Share Award Vesting
Smith & Nephew Sees Increased Stake by BlackRock
Medical Tapes Industry Report 2024, With Profiles of Leading Companies, Including 3M, Johnson & Johnson, Smith & Nephew, B. Braun Melsungen and Molnlycke Health Care
Smith & Nephew: Positioned for Growth With Strong Market Performance and Strategic Initiatives
Smith & Nephew Plc (LON:SN.) Is a Favorite Amongst Institutional Investors Who Own 77%
UBS Upgrades U.S., UK Equity Markets, Downgrades Europe
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
Investors Call for Spinoff of Smith & Nephew's Orthopaedics Unit, the Financial Times Says, Citing Sources
Smith & Nephew Executives Boost Share Holdings
Smith & Nephew Investors May Push for Breakup - Mail on Sunday
Berenberg Bank Initiates Smith & Nephew(SNN.US) With Hold Rating, Announces Target Price $27.27
Smith & Nephew Price Target Lowered to 1,400 GBp From 1,500 GBp at RBC Capital
Smith & Nephew (SN) Gets a Buy From RBC Capital
Smith & Nephew Plc (SNN) Q3 2024 Earnings Conference Call Transcript Summary
Smith & Nephew Plc (SNN) Q3 2024 Earnings Conference Call Transcript
BofA Securities Maintains Smith & Nephew(SNN.US) With Buy Rating
CCORF Maintains Smith & Nephew(SNN.US) With Hold Rating, Maintains Target Price $32
Smith & Nephew (LON:SN.) Investors Are Sitting on a Loss of 25% If They Invested Five Years Ago